PFND — Pathfinder Cell Therapy Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Pathfinder Cell Therapy, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	R2010 December 31st	2011 December 31st	2012 December 31st	C2013 December 31st	2014 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	0.015	0.196	0.009	0.044	0.026
Net Total Accounts Receivable
Net Total Receivables	0	0.054	0.028	—	—
Total Inventory
Prepaid Expenses
Total Current Assets	0.029	0.416	0.148	0.119	0.073
Net Property, Plant And Equipment	0	0.001	0	—	—
Net Intangible Assets
Total Assets	0.192	0.644	0.356	0.155	0.106
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Current Liabilities	1.24	1.13	2.98	4.71	6.05
Long Term Debt
Total Long Term Debt
Total Debt
Total Liabilities	1.32	1.35	3.21	4.71	6.05
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	-1.13	-0.707	-2.85	-4.55	-5.94
Total Liabilities & Shareholders' Equity	0.192	0.644	0.356	0.155	0.106
Total Common Shares Outstanding